Prognosis Value of Bioimpedance Analysis (BIA) Phase Angle at Admission in Intensive Care Unit (ICU) Patients

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 1, 2013

Primary Completion Date

August 15, 2014

Study Completion Date

August 31, 2014

Conditions
Intensive Care Unit Patients
Trial Locations (10)

1070

Erasme University Hospital, Brussels

1211

Geneva University Hospital, Geneva

49100

Rabin Medical Center, Petah Tikva

63009

Clermont-Ferrand University Hospital, Clermont-Ferrand

76031

Rouen University Hospital, Rouen

Unknown

Universidade Federal de Pelotas, Pelotas

Zagreb

Univ. Hospital Center Zagreb, Zagreb

08661

Vilnius University Hospital, Vilnius

32-050

Stanley Dudrick's Memorial Hospital, Skawina

07010

Clinica USP Palmaplanas, Palma de Mallorca

All Listed Sponsors
collaborator

University Hospital, Clermont-Ferrand

OTHER

collaborator

Erasme University Hospital

OTHER

collaborator

Federal University of Pelotas

OTHER

collaborator

Clinical Hospital Centre Zagreb

OTHER

collaborator

University Hospital, Rouen

OTHER

collaborator

Rabin Medical Center

OTHER

collaborator

Vilnius University

OTHER

collaborator

Stanley Dudrick's Memorial Hospital

OTHER

collaborator

Clinica USP Palmaplanas

UNKNOWN

lead

University Hospital, Geneva

OTHER

NCT01907347 - Prognosis Value of Bioimpedance Analysis (BIA) Phase Angle at Admission in Intensive Care Unit (ICU) Patients | Biotech Hunter | Biotech Hunter